Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

International Stem Cell (ISCO) Profit After Tax (2016 - 2025)

Historic Profit After Tax for International Stem Cell (ISCO) over the last 17 years, with Q3 2025 value amounting to $57000.0.

  • International Stem Cell's Profit After Tax rose 14560.0% to $57000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$59000.0, marking a year-over-year increase of 9129.79%. This contributed to the annual value of -$209000.0 for FY2024, which is 5954.2% down from last year.
  • Latest data reveals that International Stem Cell reported Profit After Tax of $57000.0 as of Q3 2025, which was up 14560.0% from $129000.0 recorded in Q2 2025.
  • In the past 5 years, International Stem Cell's Profit After Tax registered a high of $492000.0 during Q2 2023, and its lowest value of -$599000.0 during Q1 2021.
  • Its 5-year average for Profit After Tax is -$86315.8, with a median of -$34000.0 in 2023.
  • Within the past 5 years, the most significant YoY rise in International Stem Cell's Profit After Tax was 2470000.0% (2023), while the steepest drop was 209130.43% (2023).
  • Quarter analysis of 5 years shows International Stem Cell's Profit After Tax stood at -$351000.0 in 2021, then soared by 106.55% to $23000.0 in 2022, then plummeted by 2091.3% to -$458000.0 in 2023, then surged by 102.4% to $11000.0 in 2024, then surged by 418.18% to $57000.0 in 2025.
  • Its Profit After Tax stands at $57000.0 for Q3 2025, versus $129000.0 for Q2 2025 and -$256000.0 for Q1 2025.